322
Views
2
CrossRef citations to date
0
Altmetric
Think Piece

Alcohol use disorder conceptualizations and diagnoses reflect their sociopolitical context

ORCID Icon, ORCID Icon, , , , , , , , ORCID Icon & ORCID Icon show all
Pages 307-312 | Received 04 May 2022, Accepted 18 Nov 2022, Published online: 06 Dec 2022

References

  • Alcoholics Anonymous. 1939. Alcoholics Anonymous: the story of how more than one hundred men have recovered from alcoholism. New York (NY): Alcoholics Anonymous World Services.
  • American Psychiatric Association. 1952. Mental disorders: diagnostic and statistical manual. Mental Hospital Service. Washington (DC): American Psychiatric Association.
  • American Psychiatric Association. 1980. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington (DC): American Psychiatric Association.
  • American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): American Psychiatric Association.
  • American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (VA): American Psychiatric Association.
  • Boness CL, Watts AL, Moeller KN, Sher KJ. 2021. The etiologic, theory-based, ontogenetic hierarchical framework of alcohol use disorder: a translational systematic review of reviews. Psychol Bull. 147(10), 1075–1123.
  • Caetano R. 2011. There is potential for cultural and social bias in DSM-V: commentaries. Addiction. 106(5):885–887.
  • Campbell ND. 2011. The metapharmacology of the “addicted brain”. Hist Present. 1(2):194–218.
  • Camplain R, Camplain C, Trotter RT, Pro G, Sabo S, Eaves E, Peoples M, Baldwin JA. 2020. Racial/ethnic differences in drug-and alcohol-related arrest outcomes in a Southwest County from 2009 to 2018. Am J Public Health. 110(S1):S85–S92.
  • Compton WM, Guze SB. 1995. The neo-Kraepelinian revolution in psychiatric diagnosis. Eur Arch Psychiatry Clin Neurosci. 245(4–5):196–201.
  • Edman J. 2009. What’s in a name?: alcohol and drug treatment and the politics of confusion. Nord Stud Alcohol Drugs. 26(4):339–353.
  • Edwards G, Gross MM. 1976. Alcohol dependence: provisional description of a clinical syndrome. Br Med J. 1(6017):1058–1061.
  • Frances AJ. 2009. A warning sign on the road to DSM-V: beware of its unintended consequences. Psychiatr Times. 26(8):1–5. 4–8–9.
  • Gelernter J, Gueorguieva R, Kranzler HR, Zhang H, Cramer J, Rosenheck R, Krystal JH. 2007. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study. Alcohol Clin Exp Res. 31(4):555–563.
  • Hanson DJ. 1995. Preventing alcohol abuse: alcohol, culture, and control. Westport (CT): Greenwood Publishing Group.
  • Hasin DS, O'Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, Compton WM, Crowley T, Ling W, Petry NM, et al. 2013. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry. 170(8):834–851.
  • Heather N. 2013. Is alcohol addiction usefully called a disease? Philos Psychiatry Psychol. 20(4):321–324.
  • Heather N. 2017. Q: is addiction a brain disease or a moral failing? A: neither. Neuroethics. 10(1):115–124.
  • Heather N, Best D, Kawalek A, Field M, Lewis M, Rotgers F, Wiers RW, Heim D. 2018. Challenging the brain disease model of addiction: European launch of the addiction theory network. Addict Res Theory. 26(4):249–255.
  • Institute of Medicine of the National Academy of Sciences. 1990. National priorities for the assessment of clinical conditions and medical technologies: report of a pilot study. Washington (DC): The National Academies Press. https://www.nap.edu/catalog/1529/national-priorities-for-the-assessment-of-clinical-conditions-and-medical-technologies.
  • Jellinek EM. 1960. The disease concept of alcoholism. New Haven: Hillhouse Press. [accessed 2021 May 5]. http://content.apa.org/books/14090-000.
  • Jordan A, Jegede O. 2020. Building outreach and diversity in the field of addictions: building outreach and diversity. Am J Addict. 29(5):413–417.
  • Kawa S, Giordano J. 2012. A brief historicity of the Diagnostic and Statistical Manual of Mental Disorders: issues and implications for the future of psychiatric canon and practice. Philos Ethics Humanit Med. 7(1):2.
  • Keyser‐Marcus LA, Ramey T, Bjork J, Adams A, Moeller FG. 2021. Development and feasibility study of an addiction‐focused phenotyping assessment battery. Am J Addict. 30(4):398–405.
  • Kirmayer LJ. 1998. The fate of culture in DSM-IV. Transcult Psychiatry. 35(3):339–342.
  • Koob GF, Moal ML. 1997. Drug abuse: hedonic homeostatic dysregulation. Science. 278(5335):52–58.
  • Koob GF, Volkow ND. 2010. Neurocircuitry of addiction. Neuropsychopharmacology. 35(1):217–238.
  • Kranzler HR, Covault J, Feinn R, Armeli S, Tennen H, Arias AJ, Gelernter J, Pond T, Oncken C, Kampman KM. 2014. Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism. Am J Psychiatry. 171(4):445–452.
  • Krueger RF, Kotov R, Watson D, Forbes MK, Eaton NR, Ruggero CJ, Simms LJ, Widiger TA, Achenbach TM, Bach B, et al. 2018. Progress in achieving quantitative classification of psychopathology. World Psychiatry. 17(3):282–293.
  • Kwako LE, Momenan R, Litten RZ, Koob GF, Goldman D. 2016. Addictions neuroclinical assessment: a neuroscience-based framework for addictive disorders. Biol Psychiatry. 80(3):179–189.
  • Lazaroff AM. 2006. The role of the diagnostic and statistical manual of mental disorders in the maintenance of the subjugation of women: implications for the training of future mental health professionals. Forum on Public Policy: A Journal of the Oxford Round Table. Gale Academic OneFile. [accessed 2022 Nov 21]. link.gale.com/apps/doc/A175164813/AONE?u = anon ∼ f8b282a9&sid = googleScholar&xid = 85b544ab.
  • Lender ME, Martin JK. 1987. Drinking in America: a history. New York (NY): The Free Press.
  • Leshner AI. 1997. Addiction is a brain disease, and it matters. Science. 278(5335):45–47.
  • Levine H. 1983. The Good Creature of God and the demon rum: colonial American and 19th century ideas about alcohol, crime and accidents. In: alcohol and Disinhibition: nature and Meaning of the Link. Washington (DC): U.S.G.P.O. (NIAAA Monograph 12).
  • Levine HG. 1978. The discovery of addiction. J Stud Alcohol. 39(1):143–174.
  • Litten RZ, Ryan M, Falk DE, Reilly M, Fertig JB, Koob F. 2015. Heterogeneity of alcohol use disorder: understanding mechanisms to advance personalized treatment. Alcohol Clin Exp Res. 39(4):579–584.
  • Mann K, Roos CR, Hoffmann S, Nakovics H, Leménager T, Heinz A, Witkiewitz K. 2018. Precision medicine in alcohol dependence: a controlled trial testing pharmacotherapy response among reward and relief drinking phenotypes. Neuropsychopharmacology. 43(4):891–899.
  • Mezzich JE, Kirmayer LJ, Kleinman A, Fabrega HJ, Parron DL, Good BJ, Lin K-M, Manson SM. 1999. The place of culture in DSM-IV. J Nerv Ment Dis. 187(8):457–464.
  • Miller WR. 1993. Alcoholism: toward a better disease model. Psychol Addict Behav. 7(2):129–136.
  • Miller WR, Kurtz E. 1994. Models of alcoholism used in treatment: contrasting AA and other perspectives with which it is often confused. J Stud Alcohol. 55(2):159–166.
  • Millon T, Klerman GL, editors. 1986. Contemporary directions in psychopathology: toward the DSM-IV. New York: Guilford Press.
  • Nathan PE, Conrad M, Skinstad AH. 2016. History of the concept of addiction. Annu Rev Clin Psychol. 12(1):29–51.
  • National Council on Alcoholism. 1972. Criteria for the diagnosis of alcoholism. Am J Psychiatry. 129(2):127–135.
  • Pickard H. 2022. Is addiction a brain disease? A plea for agnosticism and heterogeneity. Psychopharmacology. 239(4):993–1007.
  • Rachlin H, Battalio R, Kagel J, Green L. 1981. Maximization theory in behavioral psychology. Behav Brain Sci. 4(3):371–388.
  • Rehm J. 2016. How should prevalence of alcohol use disorders be assessed globally? Alcohol Use Disord Mortal Syst Rev Meta-Anal. 25(2):79–85.
  • Robinson S, Adinoff B. 2016. The classification of substance use disorders: historical, contextual, and conceptual considerations. Behav Sci. 6(3):18.
  • Roizen. n.d. How does the nation’s “alcohol problem” change from era to era? [accessed 2022 Aug 12]. http://www.roizen.com/ron/postrepeal.htm.
  • Room R. 1985. Dependence and society. Br J Addict. 80(2):133–139.
  • Room R. 2006. Taking account of cultural and societal influences on substance use diagnoses and criteria. Addiction. 101:31–39.
  • Satel SL, Lilienfeld SO. 2017. If addiction is not best conceptualized a brain disease, then what kind of disease is it? Neuroethics. 10(1):19–24.
  • Schacht JP, Randall PK, Latham PK, Voronin KE, Book SW, Myrick H, Anton RF. 2017. Predictors of naltrexone response in a randomized trial: reward-related brain activation, OPRM1 genotype, and smoking status. Neuropsychopharmacol. 42(13):2640–2653.
  • Sedler MJ. 2016. Medicalization in psychiatry: the medical model, descriptive diagnosis, and lost knowledge. Med Health Care Philos. 19(2):247–252.
  • Stull SW, Smith KE, Vest NA, Effinger DP, Epstein DH. 2022. Potential value of the insights and lived experiences of addiction researchers with addiction. J Addict Med. 16(2):135–137.
  • Tucker J, Chandler S, Witkiewitz K. 2020. Epidemiology of recovery from alcohol use disorder. Alcohol Res. 40(3):02.
  • Valverde M. 1997. ‘Slavery from within’: the invention of alcoholism and the question of free will∗. Soc Hist. 22(3):251–268.
  • Velásquez RJ, Johnson R, Brown-Cheatham M. 1993. Teaching counselors to use the DSM-III-R with ethnic minority clients: a paradigm. Couns Educ Superv. 32(4):323–331.
  • Volkow ND, Koob GF, McLellan AT. 2016. Neurobiologic advances from the brain disease model of addiction. Longo DL, editor. N Engl J Med. 374(4):363–371.
  • Wakefield JC. 2022. Klerman’s “credo” reconsidered: neo‐Kraepelinianism, Spitzer’s views, and what we can learn from the past. World Psychiatry. 21(1):4–25.
  • Witkiewitz K, Roos CR, Mann K, Kranzler HR. 2019. Advancing precision medicine for alcohol use disorder: replication and extension of reward drinking as a predictor of naltrexone response. Alcohol Clin Exp Res. 43(11):2395–2405.
  • Zachar P, Regier DA, Kendler KS. 2019. The aspirations for a paradigm shift in DSM-5: an oral history. J Nerv Ment Dis. 207(9):778–784.
  • Zur O, Nordmarken N. n.d. DSM: diagnosing for status and money. Summary of the critique of the DSM. https://www.zurinstitute.com/resources/dsm-critique/.
  • Watts AL, Latzman RD, Boness CL, Kotov R, Keyser-Marcus L, DeYoung CG, Krueger R, Zald D, Moeller FG, Ramey T. 2022. New approaches to deep phenotyping in addictions. Psychol Addict Behav. DOI: 10.1037/adb0000878

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.